1. ADORINI L, PRUZANSKI M, SHAPIRO D: Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis. Drug Discov Today 17: 988-997, 2012.
2. American Society of Health System Pharmacists 2016a, Inc., DynaMed [Internet]. Ipswich (MA): EBSCO Information Services. 1995 - Record No. 900215, Chenodiol; [updated 2016 Jan 19, 20.07. 2016]; Available from http://search.ebscohost.com/login.aspx?direct=true&db=dnh&AN=900215&site=dynamed-live&scope=site.
3. American Society of Health System Pharmacists 2016b, Inc., DynaMed [Internet]. Ipswich (MA): EBSCO Information Services. 1995 - Record No. 526120, Ursodiol; [updated 2011 Jun 28, 20.07. 2016]; available from http://search.ebscohost.com/login.aspx?direct=true&db=dnh&AN=526120&site=dynamed-live&scope=site.
4. BALANDRAUD-PIERI N, QUENEAU PE, CAROLIBOSC FX, BERTAULTPERES P, MONTET AM, DURAND A, MONTET JC: Effects of tauroursodeoxycholate solutions on cyclosporin a bioavailability in rats. Drug Metab Dispos 25: 912-916, 1997.
5. BECQUEMONT L, GLAESER H, DRESCHER S, HITZL M, SIMON N, MURDTER T, HEINKELE G, HOFMANN U, SCHAEFER C, BURK O, VERSTUYFT C, EICHELBAUM M, FROMM M: Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4-dependent pharmacokinetics in humans. Clin Pharmacol Ther 79: 449-460, 2006.